# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-008423
Filing Date
2019-05-13
Accepted
2019-05-13 16:07:10
Documents
88
Period of Report
2019-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0319_immucellcorp.htm | 10-Q | 567994
2 | CERTIFICATION | f10q0319ex31_immucellcorp.htm | EX-31 | 7601
3 | CERTIFICATION | f10q0319ex32_immucellcorp.htm | EX-32 | 4376
| Complete submission text file | 0001213900-19-008423.txt |  | 4428737

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL PRESENTATION FILE | iccc-20190331_pre.xml | EX-101.PRE | 321018
5 | XBRL LABEL FILE | iccc-20190331_lab.xml | EX-101.LAB | 408858
6 | XBRL DEFINITION FILE | iccc-20190331_def.xml | EX-101.DEF | 188975
7 | XBRL SCHEMA FILE | iccc-20190331.xsd | EX-101.SCH | 55971
8 | XBRL CALCULATION FILE | iccc-20190331_cal.xml | EX-101.CAL | 64811
9 | XBRL INSTANCE FILE | iccc-20190331.xml | EX-101.INS | 783927

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 19818436
SIC: 2835 In Vitro & In Vivo Diagnostic Substances